CD163 and rheumatoid arthritis: These CD14+ CD16+ monocytes from RA patients also express CD16, CD163, and lower levels of HLA-DR and produce lower levels of TNF-α, IL-1β, and IL-6 but higher levels of IL-10 than the other monocytes19, 28, 29.